Erschienen in:
09.06.2020 | Muscle and Bone (A Bonetto and M Brotto, Section Editors)
Bone-Muscle Mutual Interactions
verfasst von:
Nuria Lara-Castillo, Mark L. Johnson
Erschienen in:
Current Osteoporosis Reports
|
Ausgabe 4/2020
Einloggen, um Zugang zu erhalten
Abstract
Purpose of Review
The purpose of this review is to describe the current state of our thinking regarding bone-muscle interactions beyond the mechanical perspective.
Recent Findings
Recent and prior evidence has begun to dissect many of the molecular mechanisms that bone and muscle use to communicate with each other and to modify each other’s function. Several signaling factors produced by muscle and bone have emerged as potential mediators of these biochemical/molecular interactions. These include muscle factors such as myostatin, Irisin, BAIBA, IL-6, and the IGF family and the bone factors FGF-23, Wnt1 and Wnt3a, PGE2, FGF9, RANKL, osteocalcin, and sclerostin.
Summary
The identification of these signaling molecules and their underlying mechanisms offers the very real and exciting possibility that new pharmaceutical approaches can be developed that will permit the simultaneous treatments of diseases that often occur in combination, such as osteoporosis and sarcopenia.